AXQ Capital’s BioNTech BNTX Stock Holding History

AXQ Capital’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,800	Closed	-$304K	–	651
2023 Q3	$304K	Buy	+2,800	New	+$310K	0.11%	306
2023 Q2	–	Sell	-2,300	Closed	-$287K	–	309
2023 Q1	$287K	Buy	+2,300	New	+$316K	0.11%	320

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AGA

Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

AXQ Capital's BNTX Position: Q4 2023 in Review

AXQ Capital sold out of BioNTech (BNTX) in Q4 2023, closing a stake of 2,800 shares — an estimated $304K sold.

AXQ Capital first reported a position in BNTX in Q1 2023 and held it in 2 quarters. The position peaked at $304K in Q3 2023. 282 funds tracked by Wall St. Rank hold BNTX as of Q4 2023.

AXQ Capital reported no remaining BioNTech position as of Q4 2023 after selling out during the quarter.
AXQ Capital sold 2,800 BioNTech shares in Q4 2023, an estimated $304K.
AXQ Capital first reported a position in BioNTech in Q1 2023 and held it in 2 quarters.
AXQ Capital's BioNTech position peaked at $304K in Q3 2023.
282 funds tracked by Wall St. Rank held BioNTech as of Q4 2023.

Based on AXQ Capital's 13F filing for Q4 2023, filed 13 Feb 2024.